Formulation and evaluation of pulsatile drug delivery system for chronobiological disorder: Asthma
Keywords:
Pulsatile drug delivery system, Lag time, Circadian rhythm, Eudragit S100Abstract
The objective of the present study was to develop and evaluate an oral pulsatile drug delivery system to mimic the circadian rhythm of the disease by releasing the drug with a distinct predetermined lag time of 6 h (± 0.25 h). The basic design of the system consisted of a rapid release tableted core and a controlled release tableted coat. A combination of Isopropyl Alcohol (70%) and Acetone (30%) was used as solvent for Eudragit S100 coating. An in vitro dissolution study of the prepared tablet was conducted initially for 2 h in simulated gastric fluid and after that medium was changed to intestinal fluid pH 7.4.
References
Geest S, Koker J, Demeester J, De Smedt S,
Hennink WE. Pulsed in vitro release and in
vivo behavior of exploding microcapsules.
J. Control. Release 2009;135:268–73.
Dashevsky A, Mohamad A. Development
of pulsatile multiparticulate drug delivery
system coated with aqueous dispersion
Aquacoat® ECD. Int. J. Pharm.
;318:124-31.
Qureshi J, Amir M, Ahuja A, Baboota S,
Ali J. Chronomodulated drug delivery
system of salbutamol sulphate for the
treatment of nocturnal asthma. Indian J.
Pharm. Sci. 2008;70(3):351-356.
Bi-Botti, Youan C. Chronopharmaceutics:
gimmick or clinically relevant approach to
drug delivery? J. Control. Release
;98:337-53.
Gandhi BR, Mundada AS, Gandhi PP.
Chronopharmaceutics: As a clinically
relevant drug delivery system. Drug Deliv.
;18(1):1-18.
www.pharmainfo.net
www.aapspharmascitech.com
Amin PD, Gupta SS, Prabhu NB,
Wadhwani AR. Fast disintegrating dosage
form of ofloxacin and Metronidazole
benzoate. Indian Drugs 2005;42(9):614-7.
USP 28-NF 23. The official Compendia of
Standards, Asian Edition. United States
Pharmacopoeial Convention, Inc. 2005;p.
-27.
Kaushik D, Dureja H, Saini TR.
Formulation and evaluation of Olanzapine
mouth dissolving tablets by effervescent
formulation approach. Indian Drugs
;41(7):410-2.
Rowe RC, Sheskey PJ, Owen SC.
Handbook of Pharmaceutical Excipients. 5th
ed. Pharmaceutical Press and the American
Pharmacists Association; 2006;p. 556-57
Swarbrick J. Aqueous Polymeric Coatings
for Pharmaceutical Dosage Forms. 3rd
edition. Informa Healthcare; 2005;p.305-06.
Chauhan CS, Naruka PS, Rathore RS,
Badadwal V. Formulation and evaluation of
Prednisolone tablet for colon targeted drug
delivery system. J. Chem. Pharm. Res.
;2(4):993-98.
Bussmer T, Peppas NA, Bodmeier R.
Evaluation of the swelling, hydration and
rupturing properties of the swelling layer of
a rupturable pulsatile drug delivery system.
Eur J Pharm Biopharm. 2003;56(2):261-70.
Sahoo J, Murthy PN, Biswal S, Sahoo SK,
Mahapatra AK. Comparative study of
Propranolol hydrochloride release from
matrix tablets with Kollidon® SR or
Hydroxypropyl methyl cellulose. AAPS
PharmSciTech 2008;9:577-82.
Jeffery GH, Bassett J, Mendhan J, Denney
RC. Vogel’s Textbook of Quantitative
Chemical Analysis. 5th edition. 1994;p.741-
Reddy K, Mutalik S, Reddy S. Once daily
sustained release matrix tablets of
nicorandil: formulation and in-vitro
evaluation. AAPS Pharm SciTech 2003;4:1-
Williams WD, Infrared spectrophotometry.
In; Beckett AH, Stenlake JB. Practical
pharmaceutical chemistry. Volume-II. 3rd
edition. CBS publication; 1986;p.331-60.
Stuart B, Biological applications of Infrared
spectroscopy. Wiley India edition.
;p.59-84.
Indian Pharmacopoeia. Govt. of India.
Ministry of Health and Family Welfare. The
Indian Pharmacopoeial commission.
Ghaziabad. 2007;p.409.
